China began an antitrust probe into Uralkali PJSC as little as a month before the country and the biggest potash producer are set to negotiate prices for supplies of the fertilizer.
Russia’s Economy Minister Alexei Ulyukayev hopes China’s decision in the case will be fair and the issue resolved, he told reporters after meeting Chinese officials, Interfax said Tuesday. The ministry’s press service confirmed the comments, while Uralkali officials declined to respond to questions.
The Berezniki, Russia-based company expects to start supply talks in December, Vladislav Lyan, its marketing director, said this week.
“China could have started the probe to have additional arguments,” Konstantin Yuminov, an analyst at Raiffeisenbank in Moscow, said by phone. The nation, the largest consumer, will probably agree to $275 a metric ton next year, down from $315 in 2015, he said.
The effect of any Chinese fine, possibly as much as $70 million, will be “negligible” given the company’s expected $2 billion of earnings before interest, taxes, deprecation and amortization, BCS Financial Group analyst Oleg Petropavlovskiy said in a report. Uralkali’s shipments of potash to China totaled about 2.3 million tons last year, BCS estimates.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas